Apnimed, Inc. (APMD) income statement
APMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026
$16.09−1.16 (-6.70%)
Close on Nov 20, 2026Market cap $77.26MP/E –Yield –
Apnimed, Inc. financial ratios
See a number that looks wrong?